Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer

The Hepatocyte growth factor (HGF)—mesenchymal-epithelial transition (MET) pathway is deregulated in several cancers and is associated with aggressive phenotype and worse prognosis. MET, a tyrosine kinase receptor activated by HGF, plays a physiological role in embryogenesis, promoting cell growth,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomedicines
Asıl Yazarlar: Della Corte, Carminia Maria, Fasano, Morena, Papaccio, Federica, Ciardiello, Fortunato, Morgillo, Floriana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2014
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5344276/
https://ncbi.nlm.nih.gov/pubmed/28548075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines2040345
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller